ECSP951576A - PROCEDURE TO PURIFY AND ISOLATE 2 '-DESOXY - 2', DIFLUORONUCLEOSIDES - Google Patents

PROCEDURE TO PURIFY AND ISOLATE 2 '-DESOXY - 2', DIFLUORONUCLEOSIDES

Info

Publication number
ECSP951576A
ECSP951576A ECSP951576A ECSP951576A EC SP951576 A ECSP951576 A EC SP951576A EC SP951576 A ECSP951576 A EC SP951576A EC SP951576 A ECSP951576 A EC SP951576A
Authority
EC
Ecuador
Prior art keywords
formula
graph
mixture
nucleoside
enriched
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Ta Sen Chou
Laurie M Poteet
Douglas Patton Kjell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP951576 priority Critical patent/ECSP951576A/en
Publication of ECSP951576A publication Critical patent/ECSP951576A/en

Links

Landscapes

  • Saccharide Compounds (AREA)

Abstract

El invento se refiere a un procedimiento para purificar y aislar un nucleósido enriquecido en el anómero beta que comprende: a) proporcionar una mezcla que contiene R¿¿ y un nuclésido enriquecido en el anómero beta, de la fórmula (gráfico), en la que cada X se selecciona independientemente entre grupos protectores de hidroxi y R¿es un núcleo base de la fórmula (gráfico), en la que W es un grupo protector de amino; y R¿¿ es un núcleo base de la fórmula (gráfico), en la que W es un protecyor de amino o hidrógeno; en un disolvente de alta ebullioción; b) diluir la mezcla con un disolvente orgánico seleccionado entre el grupo compuesto por éteres, esteres y nitrilos; c) añadir la mezcla de reacción diluida en ácido acuoso; y d) mantener la mezcla ácida asi preparada a una temperatura de 70oC a 100oC hasta que haya precipitado el producto de fórmula IB, en el que W es ahora W.The invention relates to a process for purifying and isolating a nucleoside enriched in the beta anomer comprising: a) providing a mixture containing R¿¿ and a nucleoside enriched in the beta anomer, of the formula (graph), in which each X is independently selected from hydroxy protecting groups and R¿ is a base nucleus of the formula (graph), wherein W is an amino protecting group; and R¿¿ is a base nucleus of the formula (graph), in which W is a protecyor of amino or hydrogen; in a high boiling solvent; b) diluting the mixture with an organic solvent selected from the group consisting of ethers, esters and nitriles; c) adding the reaction mixture diluted in aqueous acid; and d) maintaining the acidic mixture thus prepared at a temperature of 70oC to 100oC until the product of formula IB, where W is now W., has precipitated.

ECSP951576 1995-11-09 1995-11-09 PROCEDURE TO PURIFY AND ISOLATE 2 '-DESOXY - 2', DIFLUORONUCLEOSIDES ECSP951576A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP951576 ECSP951576A (en) 1995-11-09 1995-11-09 PROCEDURE TO PURIFY AND ISOLATE 2 '-DESOXY - 2', DIFLUORONUCLEOSIDES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP951576 ECSP951576A (en) 1995-11-09 1995-11-09 PROCEDURE TO PURIFY AND ISOLATE 2 '-DESOXY - 2', DIFLUORONUCLEOSIDES

Publications (1)

Publication Number Publication Date
ECSP951576A true ECSP951576A (en) 1997-06-27

Family

ID=42042218

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP951576 ECSP951576A (en) 1995-11-09 1995-11-09 PROCEDURE TO PURIFY AND ISOLATE 2 '-DESOXY - 2', DIFLUORONUCLEOSIDES

Country Status (1)

Country Link
EC (1) ECSP951576A (en)

Similar Documents

Publication Publication Date Title
CO4600741A1 (en) PROCEDURE TO PURIFY AND ISOLATE 2´-DESOXI-2´, 2´-DI- FLUORONUCLEOSIDES
BR9812944A (en) Bicyclic kinase inhibitors
PT92935A (en) METHOD FOR PREPARING A PYRAZOLE-PYRIDINE COMPOUND AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
PT98720A (en) PROCESS FOR THE PREPARATION OF PHOSPHOLIPID DERIVATIVES FROM NUCLEOSIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR9914696A (en) Compound, process for treating cyclooxygenase-2-mediated disorder in an individual, and pharmaceutical composition
DK0659174T3 (en) Derivatives of valproic acid and 2-valproic acid amides as well as their use as anticonvulsants
ES2149340T3 (en) GLUCOSAMINE DISACARIDS, METHOD FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM, AND ITS USE.
KR830006174A (en) Bronchial Anticonvulsant Compounds
BR9807349A (en) Compound, processes for preparing a compound and for preparing 6-o-alkyl erythromycin a.
ES2131972T3 (en) DERIVATIVES OF SULFAMATE OF DERIVATIVES OF 1,3,5 (10) -STRATRIENE, PROCEDURE FOR ITS MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS.
DE69107512D1 (en) Derivatives of endogenous mediators, their salts, processes for their preparation, applications and compositions containing them.
CY2184B1 (en) Process for the preparation of n-acetyl neuraminicacid derivatives
PT81345B (en) METHOD FOR PREPARING NEW ACTIVE PEPTIDEES ON THE CENTRAL NERVOUS SYSTEM WITH ACTION ON THE COLINERGIC SYSTEM, AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
BR0111897A (en) Compound, method for treating an individual afflicted with some disorders of the peripheral and central nervous systems, pharmaceutical composition, and use of a compound
ES8706148A1 (en) Carbapenem compounds, their preparation and use.
ECSP951576A (en) PROCEDURE TO PURIFY AND ISOLATE 2 '-DESOXY - 2', DIFLUORONUCLEOSIDES
UY25807A1 (en) SUBSTITUTED CAPROLACTAMAS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, AND THEIR USE IN THE TREATMENT OF TUMORS.
DK0644196T3 (en) TTTr as a protecting group in nucleotide synthesis
IL108856A0 (en) Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
ES8507136A1 (en) A PROCEDURE FOR THE PREPARATION OF ANTHRACICLINE GLYCOSIDES
PT93071A (en) METHOD FOR PREPARING NEW 4'-EPI-4'-AMINO-ANTHRACYCLINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU9080398A (en) Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them
BR0004764A (en) Cyanoindole serotonin resuscitation inhibiting compounds, a process for their preparation and pharmaceutical compositions containing them
ES2062135T3 (en) DERIVATIVES OF THE TENYLACETIC ACID, PROCEDURE FOR ITS OBTAINING, ITS EMPLOYMENT, AS WELL AS MEDICINES THAT CONTAIN THIS AND ITS OBTAINING.
ES2175513T3 (en) USE OF A CRYSTALLIZING INHIBITING ADDITIVE FOR NON-IONIC TENSIOACTIVE GLUCOSIDS.